Home Newsfeeds JP Morgan Maintains Neutral on Ormat Technologies, Raises Price Target to $80

JP Morgan Maintains Neutral on Ormat Technologies, Raises Price Target to $80

JP Morgan analyst Mark Strouse maintains Ormat Technologies (NYSE:ORA) with a Neutral and raises the price target from $77 to $80.

byBenzinga Newsdesk

July 20, 2022

1 minute read

JP Morgan analyst Mark Strouse maintains Ormat Technologies (NYSE:ORA) with a Neutral and raises the price target from $77 to $80.

News

Beam Therapeutics Reports Progress Across Base Editing Portfolio And Outlines Key Anticipated Milestones

By Benzinga Newsdesk

January 9, 7:42 AM

BEACON Trial of BEAM-101 in Sickle Cell Disease Ongoing with Data from Multiple Patients Expected in 2024; Expansion Phase Initiation Expected in 2023 First Patient Dosing in BEAM-201 Trial in Patients with

BEAM

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $44

By Benzinga Newsdesk

December 19, 9:45 AM

Morgan Stanley analyst Hamza Fodderwala maintains Rapid7 (NASDAQ:RPD) with a Equal-Weight and lowers the price target from $55 to $44.

RPD

TILT Debuts Social Impact Driven Brand Black Buddha Cannabis In Massachusetts, This State Is Next

By Jelena Martinovic

October 6, 11:56 AM

TILT Holdings Inc. (NEO: TILT) (OTCQX: TLLTF) announced on Thursday the Massachusetts launch of Black Buddha Cannabis, a Black and woman-owned and led environmentally conscious, social impact-driven cannabis wellness brand.

TLLTF

Why Bed Bath & Beyond Shares Are Getting Hammered

By Henry Khederian

February 8, 1:36 PM

Bed Bath & Beyond Inc (NASDAQ: BBBY) shares are trading lower by 13.95% to $2.59 during Wednesday's session on continued downward momentum following Monday's short squeeze volatility.

BBBY

JP Morgan Maintains Neutral on Ormat Technologies, Raises Price Target to $80

Related Posts

Beam Therapeutics Reports Progress Across Base Editing Portfolio And Outlines Key Anticipated Milestones

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $44

TILT Debuts Social Impact Driven Brand Black Buddha Cannabis In Massachusetts, This State Is Next

Why Bed Bath & Beyond Shares Are Getting Hammered